Dr John Joseph Kirkowski, DO | |
127 Sullivan St, Canton, PA 17724-1733 | |
(570) 673-3197 | |
(570) 673-8297 |
Full Name | Dr John Joseph Kirkowski |
---|---|
Gender | Male |
Speciality | Family Medicine |
Location | 127 Sullivan St, Canton, Pennsylvania |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1558476648 | NPI | - | NPPES |
101235309 | Medicaid | PA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | OS003118L (Pennsylvania) | Primary |
Entity Name | Guthrie Medical Group Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1962451153 PECOS PAC ID: 6002728656 Enrollment ID: O20040301000571 |
News Archive
U of S researchers have discovered the chemical pathway that Cannabis sativa uses to create bioactive compounds called cannabinoids, paving the way for the development of marijuana varieties to produce pharmaceuticals or cannabinoid-free industrial hemp.
PBS NewsHour on Monday aired the second installment in its "Food for 9 Billion" series, in which "Sam Eaton of Homelands Productions goes to the fishing village of Humay-Humay" in the Philippines and "speaks with families about their concerns that future generations won't enjoy the same access to fish as a food staple and way of life," the PBS NewsHour blog "The Rundown" reports.
Researchers from the Duke Human Vaccine Institute and Duke University, Durham NC, USA, recently analyzed the D614G mutation in SARS-CoV-2 in the context of a soluble S ectodomain construct. Their study has been published in the preprint server bioRxiv.
Allergan plc., a leading global pharmaceutical company today announced that its Phase III ready investigational medication rapastinel (GLYX-13) received Breakthrough Therapy designation from the U.S. Food and Drug Administration for adjunctive treatment of Major Depressive Disorder (MDD).
Can coronavirus disease 2019 (COVID-19) affect the eye? New research suggests the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can enter the eye and infect photoreceptor and retinal ganglion cells. In addition, SARS-CoV-2 infection increases the expression of several inflammatory genes, including the cytokine interleukin 33 (IL33), which is linked to COVID-19 disease and retinal degeneration.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr John Joseph Kirkowski, DO 1 Guthrie Sq, Sayre, PA 18840-1625 Ph: (570) 888-5858 | Dr John Joseph Kirkowski, DO 127 Sullivan St, Canton, PA 17724-1733 Ph: (570) 673-3197 |
News Archive
U of S researchers have discovered the chemical pathway that Cannabis sativa uses to create bioactive compounds called cannabinoids, paving the way for the development of marijuana varieties to produce pharmaceuticals or cannabinoid-free industrial hemp.
PBS NewsHour on Monday aired the second installment in its "Food for 9 Billion" series, in which "Sam Eaton of Homelands Productions goes to the fishing village of Humay-Humay" in the Philippines and "speaks with families about their concerns that future generations won't enjoy the same access to fish as a food staple and way of life," the PBS NewsHour blog "The Rundown" reports.
Researchers from the Duke Human Vaccine Institute and Duke University, Durham NC, USA, recently analyzed the D614G mutation in SARS-CoV-2 in the context of a soluble S ectodomain construct. Their study has been published in the preprint server bioRxiv.
Allergan plc., a leading global pharmaceutical company today announced that its Phase III ready investigational medication rapastinel (GLYX-13) received Breakthrough Therapy designation from the U.S. Food and Drug Administration for adjunctive treatment of Major Depressive Disorder (MDD).
Can coronavirus disease 2019 (COVID-19) affect the eye? New research suggests the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can enter the eye and infect photoreceptor and retinal ganglion cells. In addition, SARS-CoV-2 infection increases the expression of several inflammatory genes, including the cytokine interleukin 33 (IL33), which is linked to COVID-19 disease and retinal degeneration.
› Verified 9 days ago
Dr. John Harold Weis, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 61 Sullivan St, Canton, PA 17724 Phone: 570-673-3197 Fax: 570-673-8297 |